This research study is evaluating the safety and efficacy of an investigational medication in patients with moderate to severe Hidradenitis Suppurativa.
Study participants must be at least 18 years of age and have a diagnosis of Hidradenitis Suppurativa for at least one year (365 days).
The duration of the study is approximately 50 weeks, and participants are asked to visit the study centre approximately 13 times. There is no cost to participate and reimbursement is available for the travel associated with the study.
The study is being conducted by Dermatologists who specialize in the assessment of Hidradenitis Suppurativa.
For more information please contact the Dermatology clinic near you.
All information about you will be kept confidential.
If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.
Regulatory agencies like Health Canada and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more